第7章 質譜分析市場分析

質譜分析市場概要

研究 vs. 臨床質量

質譜分析市場:地區分佈

質譜分析市場:市場佔有率，各企業

質譜分析市場 (銷售到臨床實驗室的產品) :作為對象的臨床類別

質譜分析市場:質譜儀類別

第8章 企業簡介:質譜分析企業

圖表清單

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Product Code: KLI15217025

Mass spectrometry has been primarily used in research applications, with early applications focused on small molecules. However, development of soft-ionization techniques such as matrix-assisted laser desorption ionization (MALDI) and electrospray ionization (ESI) has made it possible to study larger molecules such as proteins, peptides, DNA, and other large molecules without extensive fragmentation, opening up a whole new world of opportunities as mass spectrometry now moves into the clinical laboratory. The Market for Mass Spectrometry in Clinical Testing Applications focuses on the worldwide market for mass spectrometry products - instruments and consumables - and includes the following information:

The report looks as well at the market drivers and challenges for mass spectrometry in the clinical lab, including the advantages and disadvantages of mass spectrometry and current trends in the mass spectrometry market.

The clinical diagnostic applications of mass spectrometry are expanding. Mass spectrometry has already had a disruptive impact on microbial identification. Mass spectrometry is now being applied to a growing number of oncology applications, and there is a growing awareness of the importance of both genomic and proteomic information for many oncology diagnostic applications. Mass spectrometry has the potential to be applied to other diagnostic applications as well, as discussed in this report.

With this market potential, many companies are making deals in this promising area. The report discusses selected investment and financing agreements in mass spectrometry companies, selected acquisitions, selected agreements between mass spectrometry companies, selected agreements between mass spectrometry platform/reagent companies and mass spectrometry software companies, selected company agreements between mass spectrometry companies and diagnostic companies or clinical laboratories, selected agreements among mass spectrometry companies and pharmaceutical or biopharmaceutical companies (includes contract research organizations providing services to pharma companies), and selected mass spectrometry company agreements with academic or other non-profit organizations.

The report includes company profiles of the players in the mass spectrometry market: